ReviewBiotechnology letters2026
Porcine pancreas lipase: a versatile biocatalyst.
Review in Biotechnology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Porcine pancreatic lipase, a 1, 3-regioselective lipase, is one of the most widely used biocatalyst in academic as well as industrial processes. This lipase showed remarkable catalytic performance, often outclassed other types of lipases in producing valuable products through varieties of reactions. During hydrolysis of vegetable oil to fatty acid, mono and diacylglycerol, porcine pancreas lipase outclassed Candia rugosa and Thermomyces lanuginosus lipase. Porcine pancreas lipase efficiently catalyzed transesterification of vegetable oil to biodiesel as well. This lipase catalyzed esterification of organic acid and alcohol, glycerol and fatty acid, sugar and fatty acid resulting in organic ester, monoacylglycerol and sugar and fatty acid ester, respectively; outperformed Candia rugosa and Rhizopus niveus lipase. Porcine pancreas lipase manifested catalytic promiscuity by conversion of 4-hydroxycoumarin and aromatic aldehyde to Bis-4-hydroxycoumarin through Knoevenagel condensation; of aromatic or heteroaromatic aldehyde and ketone to aldol through aldol condensation. It outweighed lipases from Aspergillus niger, Pesudomonas fluorescens and Candia rugosa during Michael addition between 4-hydroxycoumarin and α, β-unsaturated enones to warfarin. It outperformed Mucor javanicus lipase during cascade reaction involving aldehyde and indole to Bis(indolyl)alkanes; and Candida cylindracea lipase during enantioselective acylation between amino alcohol and acetate ester to amide and amido-ester. This lipase also catalyzed multicomponent synthesis leading to Pyrido[2,3-d]pyrimidine derivatives from aromatic aldehyde, malononitrile and 6-amino-1,3-dimethyl uracil. This lipase has potential application value as it could catalyze these reactions under milder conditions.
Indexed as
Identifiers
42801372What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.